Novoprotein Scientific Inc. (SHA:688137)

China · Delayed Price · Currency is CNY

139.41

-11.77 (-7.79%)

Oct 16, 2026, 4:00 PM EDT

Market Cap	9.69B +234.4%
Revenue (ttm)	152.84M +9.2%
Net Income	-82.76M
EPS	-1.18
Shares Out	69.51M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,181,940
Open	149.99
Previous Close	151.18
Day's Range	137.56 - 159.99
52-Week Range	33.20 - 168.03
Beta	1.27
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 30, 2026

About Novoprotein Scientific

Novoprotein Scientific Inc. researches, develops, produces, and sells raw materials and technology solutions for biopharmaceuticals enterprises. The company offers mRNA vaccine drug raw materials, immunodiagnostic and molecular diagnostic raw materials, gene and cell therapy, molecular research reagents, cytokines, target proteins, cell lines, reference antibody, recombinant antibodies, enzymes and reagents, matrix gel and culture medium, and protein and virus research related products. It offers its products and services in the fields of bioph... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2009

Employees 696

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 688137

Full Company Profile

Financial Performance

In 2025, Novoprotein Scientific's revenue was 146.44 million, an increase of 14.80% compared to the previous year's 127.56 million. Losses were -77.78 million, 42.9% more than in 2024.

Financial Statements